Contact
 

AIDS 2010 Activities

 

The Global HIV Vaccine Enterprise participated in numerous events at the AIDS 2010 conference in Vienna (18 – 23 July 2010). Below please find information on these activities.

 

The Road to Prevention:

The Global HIV Vaccine Enterprise releases The Road to Prevention, a new overview outlining the major opportunities and challenges in HIV vaccine research and development today. The Road to Prevention was released in advance of the launch of the Global HIV Vaccine Enterprise Scientific Strategic Plan, the plan of the Enterprise Council and a collaborative effort of more than 400 researchers worldwide, which will be released at the AIDS Vaccine 2010 conference in Atlanta, USA in September.

 

Read the Road to Prevention.

Read the Road to Prevention press release.

 

Satellite: (Sunday, 18 July, 11:15 - 13:15, Mini Room 6)

The Global HIV Vaccine Enterprise and partners presented an interactive satellite session, “The Search for an HIV Vaccine: Where are we, where are we going, and how can we get there faster?”  The session is available via webcast here.  Speakers included:

 - Linda-Gail Bekker, Desmond Tutu HIV Centre

- Seth Berkley, International AIDS Vaccine Initiative

- Alan Bernstein, Global HIV Vaccine Enterprise

- Gabriela Calazans, Unidade de Pesquisa de Vacinas Anti-HIV

- Rainer Engelhardt, Government of Canada

- Mark Feinberg, Merck & Co. Inc.

- Thumbi Ndung'u, University of KwaZulu Natal

- Peter Piot, London School of Hygiene & Tropical Medicine

- Merlin Robb, U.S. Military HIV Research Program

- Robin Shattock, St George’s Hospital Medical School

- Mitchell Warren, AVAC: Global Advocacy for HIV Prevention

 

Press Conference: (Monday, 19 July, 12 noon; AIDS 2010 Media Center press conference room 1)

Leading HIV vaccine researchers gave their perspectives on progress and challenges in HIV vaccine research and how to take the field forward.  Speakers included:

 

- Seth Berkley, International AIDS Vaccine Initiative (IAVI)

- Alan Bernstein, Global HIV Vaccine Enterprise

- José Esparza, The Bill & Melinda Gates Foundation

- Anthony Fauci, National Institutes of Allergy and Infectious Diseases (NIAID)

- Helene Gayle, President and CEO of CARE USA; U.S. Presidential Advisory Council on HIV/AIDS

- Peter Piot, London School of Hygiene and Tropical Medicine 

 

Sessions:

HIV Vaccines - Quo Vadis?” (Tuesday, July 20, 14:30 – 16:00, Session room 3)

An assessment of recent, current and planned HIV vaccine trials was chaired by José Esparza of The Bill & Melinda Gates Foundation and Seth Berkley of IAVI, and featured Alan Bernstein of the Global HIV Vaccine Enterprise.

  

Journalist-2-Journalist Training Program

The National Press Foundation and the IAS organized a training program in advance of the meeting to help prepare journalists for what they will see and hear during the meeting.  Dr. Alan Bernstein presented to journalist scholars on the state of HIV vaccine research on Friday, 16 July.

 

OCTAVE Workshop on the UNAIDS/AVAC Good Participatory Practice Guidelines

The Enterprise, in collaboration with the Online Collaborative Training for AIDS Vaccine Evaluation (OCTAVE) Project, AVAC and UNAIDS, hosted a capacity building workshop for Young and Early Career Investigator (YECIs) scholars in advance of the conference.  This is part of a series of workshops aimed at educating YECIs on HIV prevention research.

 

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account